{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:39:57Z","timestamp":1790858397935,"version":"4.1.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00415-018-9138-7","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T02:14:48Z","timestamp":1543284888000},"page":"1541-1548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Update on opsoclonus\u2013myoclonus syndrome in adults"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3174-1680","authenticated-orcid":false,"given":"Sun-Young","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Dieterich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"9138_CR1","doi-asserted-by":"publisher","unstructured":"Leigh RJ, Zee DS. The neurology of eye movements [online]. Print ISBN-13: 9780199969289. Published online: Jun 2015. \n                    https:\/\/doi.org\/10.1093\/med\/9780199969289.001.0001","DOI":"10.1093\/med\/9780199969289.001.0001"},{"key":"9138_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejpn.2009.03.002","volume":"14","author":"KK Pang","year":"2010","unstructured":"Pang KK, de Sousa C, Lang B, Pike MG (2010) A prospective study of the presentation and management of dancing eye syndrome\/opsoclonus\u2013myoclonus syndrome in the United Kingdom. Eur J Paediatr Neurol 14:156\u2013161","journal-title":"Eur J Paediatr Neurol"},{"key":"9138_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00247-009-1282-x","volume":"39","author":"AB Rothenberg","year":"2009","unstructured":"Rothenberg AB, Berdon WE, D\u2019Angio GJ, Yamashiro DJ, Cowles RA (2009) The association between neuroblastoma and opsoclonus\u2013myoclonus syndrome: a historical review. Pediatr Radiol 39:723\u2013726","journal-title":"Pediatr Radiol"},{"key":"9138_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.410290303","volume":"29","author":"FA Luque","year":"1991","unstructured":"Luque FA, Furneaux HM, Ferziger R et al (1991) Anti-Ri\u2014an antibody associated with paraneoplastic opsoclonus and breast-cancer. Ann Neurol 29:241\u2013251","journal-title":"Ann Neurol"},{"key":"9138_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/ana.10462","volume":"53","author":"L Bataller","year":"2003","unstructured":"Bataller L, Rosenfeld MR, Graus F, Vilchez JJ, Cheung NKV, Dalmau J (2003) Autoantigen diversity in the opsoclonus\u2013myoclonus syndrome. Ann Neurol 53:347\u2013353","journal-title":"Ann Neurol"},{"key":"9138_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1001\/jamaneurol.2015.4607","volume":"73","author":"T Armangue","year":"2016","unstructured":"Armangue T, Sabater L, Torres-Vega E et al (2016) Clinical and immunological features of opsoclonus\u2013myoclonus syndrome in the era of neuronal cell surface antibodies. JAMA Neurol 73:417\u2013424","journal-title":"JAMA Neurol"},{"key":"9138_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1177\/0009922808330882","volume":"48","author":"TE Herman","year":"2009","unstructured":"Herman TE, Siegel MJ (2009) Ataxia without opsoclonus: right lumbar sympathetic trunk neuroblastoma. Clin Pediatr 48:336\u2013340","journal-title":"Clin Pediatr"},{"key":"9138_CR8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ejpn.2009.12.005","volume":"14","author":"P Krug","year":"2010","unstructured":"Krug P, Schleiermacher G, Michon J et al (2010) Opsoclonus\u2013myoclonus in children associated or not with neuroblastoma. Eur J Paediatr Neurol 14:400\u2013409","journal-title":"Eur J Paediatr Neurol"},{"key":"9138_CR9","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1001\/archneur.1986.00520110055016","volume":"43","author":"KB Digre","year":"1986","unstructured":"Digre KB (1986) Opsoclonus in adults. Report of three cases and review of the literature. Arch Neurol 43:1165\u20131175","journal-title":"Arch Neurol"},{"key":"9138_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/brain\/99.1.27","volume":"99","author":"AM Whiteley","year":"1976","unstructured":"Whiteley AM, Swash M, Urich H (1976) Progressive encephalomyelitis with rigidity. Brain 99:27\u201342","journal-title":"Brain"},{"key":"9138_CR11","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/archneur.64.9.1318","volume":"64","author":"A McKeon","year":"2007","unstructured":"McKeon A, Pittock SJ, Glass GA et al (2007) Whole-body tremulousness: isolated generalized polymyoclonus. Arch Neurol 64:1318\u20131322","journal-title":"Arch Neurol"},{"key":"9138_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/1043454204272560","volume":"22","author":"ED Tate","year":"2005","unstructured":"Tate ED, Allison TJ, Pranzatelli MR, Verhulst SJ (2005) Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus\u2013myoclonus syndrome. J Pediatr Oncol Nurs 22:8\u201319","journal-title":"J Pediatr Oncol Nurs"},{"key":"9138_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1055\/s-0029-1237723","volume":"40","author":"E Grandis De","year":"2009","unstructured":"De Grandis E, Parodi S, Conte M et al (2009) Long-term follow-up of neuroblastoma-associated opsoclonus\u2013myoclonus-ataxia syndrome. Neuropediatrics 40:103\u2013111","journal-title":"Neuropediatrics"},{"key":"9138_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.canlet.2005.01.051","volume":"228","author":"KK Matthay","year":"2005","unstructured":"Matthay KK, Blaes F, Hero B et al (2005) Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004. Cancer Lett 228:275\u2013282","journal-title":"Cancer Lett"},{"key":"9138_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00002826-199619010-00001","volume":"19","author":"MR Pranzatelli","year":"1996","unstructured":"Pranzatelli MR (1996) The immunopharmacology of the opsoclonus\u2013myoclonus syndrome. Clin Neuropharmacol 19:1\u201347","journal-title":"Clin Neuropharmacol"},{"key":"9138_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/00005792-198803000-00003","volume":"67","author":"NE Anderson","year":"1988","unstructured":"Anderson NE, Buddesteffen C, Rosenblum MK et al (1988) Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer\u2014a distinct para-neoplastic syndrome. Medicine 67:100\u2013109","journal-title":"Medicine"},{"key":"9138_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/00043426-200007000-00007","volume":"22","author":"NL Antunes","year":"2000","unstructured":"Antunes NL, Khakoo Y, Matthay KK et al (2000) Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus\u2013myoclonus. J Pediatr Hematol Oncol 22:315\u2013320","journal-title":"J Pediatr Hematol Oncol"},{"key":"9138_CR18","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1212\/WNL.42.10.1931","volume":"42","author":"K Peterson","year":"1992","unstructured":"Peterson K, Rosenblum MK, Kotanides H, Posner JB (1992) Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42:1931\u20131937","journal-title":"Neurology"},{"key":"9138_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/ana.1288","volume":"50","author":"MR Rosenfeld","year":"2001","unstructured":"Rosenfeld MR, Eichen JG, Wade DF, Posner JB, Dalmau J (2001) Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol 50:339\u2013348","journal-title":"Ann Neurol"},{"key":"9138_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0022-510X(01)00564-0","volume":"189","author":"AM Wong","year":"2001","unstructured":"Wong AM, Musallam S, Tomlinson RD, Shannon P, Sharpe JA (2001) Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates. J Neurol Sci 189:71\u201381","journal-title":"J Neurol Sci"},{"key":"9138_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1001\/archneurol.2009.299","volume":"67","author":"M Kurian","year":"2010","unstructured":"Kurian M, Lalive PH, Dalmau JO, Horvath J (2010) Opsoclonus\u2013myoclonus syndrome in anti-N-methyl-d-aspartate receptor encephalitis. Arch Neurol 67:118\u2013121","journal-title":"Arch Neurol"},{"key":"9138_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/jnnp.66.2.214","volume":"66","author":"A Saiz","year":"1999","unstructured":"Saiz A, Dalmau J, Butler MH et al (1999) Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma. J Neurol Neurosurg Psychiatry 66:214\u2013217","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9138_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/brain\/124.2.437","volume":"124","author":"L Bataller","year":"2001","unstructured":"Bataller L, Graus F, Saiz A, Vilchez JJ, Spanish Opsoclonus\u2013myoclonus Study G (2001) Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus\u2013myoclonus. Brain 124:437\u2013443","journal-title":"Brain"},{"key":"9138_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","volume":"49","author":"Z Yu","year":"2001","unstructured":"Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA (2001) CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49:146\u2013154","journal-title":"Ann Neurol"},{"key":"9138_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/ana.10462","volume":"53","author":"L Bataller","year":"2003","unstructured":"Bataller L, Rosenfeld MR, Graus F, Vilchez JJ, Cheung NK, Dalmau J (2003) Autoantigen diversity in the opsoclonus\u2013myoclonus syndrome. Ann Neurol 53:347\u2013353","journal-title":"Ann Neurol"},{"key":"9138_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0165-5728(87)90088-9","volume":"15","author":"MJ Noetzel","year":"1987","unstructured":"Noetzel MJ, Cawley LP, James VL, Minard BJ, Agrawal HC (1987) Anti-neurofilament protein antibodies in opsoclonus\u2013myoclonus. J Neuroimmunol 15:137\u2013145","journal-title":"J Neuroimmunol"},{"key":"9138_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1212\/WNL.43.1_Part_1.207","volume":"43","author":"EJ Dropcho","year":"1993","unstructured":"Dropcho EJ, Kline LB, Riser J (1993) Antineuronal (anti-Ri) antibodies in a patient with steroid-responsive opsoclonus\u2013myoclonus. Neurology 43:207\u2013211","journal-title":"Neurology"},{"key":"9138_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ana.10518","volume":"53","author":"SJ Pittock","year":"2003","unstructured":"Pittock SJ, Lucchinetti CF, Lennon VA (2003) Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 53:580\u2013587","journal-title":"Ann Neurol"},{"key":"9138_CR29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/brain\/124.2.437","volume":"124","author":"L Bataller","year":"2001","unstructured":"Bataller L, Graus F, Saiz A, Vilchez JJ, Study SOM (2001) Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus\u2013myoclonus. Brain 124:437\u2013443","journal-title":"Brain"},{"key":"9138_CR30","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/jnnp.57.6.763-a","volume":"57","author":"J Scholz","year":"1994","unstructured":"Scholz J, Vieregge P, Ruff C (1994) Paraneoplastic opsoclonus\u2013myoclonus syndrome in metastatic ovarian-carcinoma. J Neurol Neurosur Ps 57:763\u2013764","journal-title":"J Neurol Neurosur Ps"},{"key":"9138_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/mds.870100106","volume":"10","author":"JN Caviness","year":"1995","unstructured":"Caviness JN, Forsyth PA, Layton DD, Mcphee TJ (1995) The movement disorder of adult opsoclonus. Mov Disord 10:22\u201327","journal-title":"Mov Disord"},{"key":"9138_CR32","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s004150050270","volume":"245","author":"JLM Jongen","year":"1998","unstructured":"Jongen JLM, Moll WJB, Smitt PAES, Vecht CJ, Tijssen CC (1998) Anti-Ri positive opsoclonus\u2013myoclonus-ataxia in ovarian duct cancer. J Neurol 245:691\u2013692","journal-title":"J Neurol"},{"key":"9138_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1046\/j.1468-1331.2000.00091.x","volume":"7","author":"R Moretti","year":"2000","unstructured":"Moretti R, Torre P, Antonello RM, Nasuelli D, Cazzato G (2000) Opsoclonus\u2013myoclonus syndrome: gabapentin as a new therapeutic proposal. Eur J Neurol 7:455\u2013456","journal-title":"Eur J Neurol"},{"key":"9138_CR34","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ygyno.2010.01.017","volume":"117","author":"E Lou","year":"2010","unstructured":"Lou E, Hensley ML, Lassman AB, Aghajanian C (2010) Paraneoplastic opsoclonus\u2013myoclonus syndrome secondary to immature ovarian teratoma. Gynecol Oncol 117:382\u2013384","journal-title":"Gynecol Oncol"},{"key":"9138_CR35","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000048454","volume":"68","author":"S Luca De","year":"2002","unstructured":"De Luca S, Terrone C, Crivellaro S et al (2002) Opsoclonus\u2013myoclonus syndrome as a paraneoplastic manifestation of renal cell carcinoma\u2014a case report and review of the literature. Urol Int 68:206\u2013208","journal-title":"Urol Int"},{"key":"9138_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11060-004-2465-9","volume":"73","author":"A Kumar","year":"2005","unstructured":"Kumar A, Lajara-Nanson WA, Neilson RW (2005) Paraneoplastic opsoclonus\u2013myoclonus syndrome: initial presentation of non-Hodgkins lymphoma. J Neuro Oncol 73:43\u201345","journal-title":"J Neuro Oncol"},{"key":"9138_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/A:1006189210197","volume":"41","author":"JR Berger","year":"1999","unstructured":"Berger JR, Mehari E (1999) Paraneoplastic opsoclonus\u2013myoclonus secondary to malignant melanoma. J Neuro Oncol 41:43\u201345","journal-title":"J Neuro Oncol"},{"key":"9138_CR38","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1007\/s00415-006-0026-1","volume":"253","author":"KY Jung","year":"2006","unstructured":"Jung KY, Youn J, Chung CS (2006) Opsoclonus\u2013myoclonus syndrome in an adult with malignant melanoma. J Neurol 253:942\u2013943","journal-title":"J Neurol"},{"key":"9138_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jneuroim.2008.05.033","volume":"201","author":"F Blaes","year":"2008","unstructured":"Blaes F, Pike MG, Lang B (2008) Autoantibodies in childhood opsoclonus\u2013myoclonus syndrome. J Neuroimmunol 201:221\u2013226","journal-title":"J Neuroimmunol"},{"key":"9138_CR40","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1001\/archneurol.2012.1173","volume":"69","author":"JP Klaas","year":"2012","unstructured":"Klaas JP, Ahlskog JE, Pittock SJ et al (2012) Adult-onset opsoclonus\u2013myoclonus syndrome. Arch Neurol 69:1598\u20131607","journal-title":"Arch Neurol"},{"key":"9138_CR41","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1212\/WNL.44.9.1754","volume":"44","author":"B Hersh","year":"1994","unstructured":"Hersh B, Dalmau J, Dangond F, Gultekin S, Geller E, Wen PY (1994) Paraneoplastic opsoclonus\u2013myoclonus associated with anti-Hu antibody. Neurology 44:1754\u20131755","journal-title":"Neurology"},{"key":"9138_CR42","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/archneurol.2011.166","volume":"68","author":"JH Smith","year":"2011","unstructured":"Smith JH, Dhamija R, Moseley BD et al (2011) N-Methyl-d-aspartate receptor autoimmune encephalitis presenting with opsoclonus\u2013myoclonus treatment response to plasmapheresis. Arch Neurol-Chicago 68:1069\u20131072","journal-title":"Arch Neurol-Chicago"},{"key":"9138_CR43","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1017\/S0317167100007915","volume":"36","author":"CB Josephson","year":"2009","unstructured":"Josephson CB, Grant I, Benstead T (2009) Opsoclonus\u2013myoclonus with multiple paraneoplastic syndromes and VGCC antibodies. Can J Neurol Sci 36:512\u2013514","journal-title":"Can J Neurol Sci"},{"key":"9138_CR44","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/jnnp.2009.172684","volume":"82","author":"RJ Simister","year":"2011","unstructured":"Simister RJ, Ng K, Lang B, Beckles M, Chao D, McCabe DJH (2011) Sequential fluctuating paraneoplastic ocular flutter-opsoclonus\u2013myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer. J Neurol Neurosur Ps 82:344\u2013346","journal-title":"J Neurol Neurosur Ps"},{"key":"9138_CR45","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1212\/01.wnl.0000313840.27060.bf","volume":"70","author":"MC Dalakas","year":"2008","unstructured":"Dalakas MC (2008) Invited article: inhibition of B cell functions\u2014implications for neurology. Neurology 70:2252\u20132260","journal-title":"Neurology"},{"key":"9138_CR46","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1212\/WNL.62.9.1526","volume":"62","author":"MR Pranzatelli","year":"2004","unstructured":"Pranzatelli MR, Travelstead AL, Tate ED et al (2004) B- and T-cell markers in opsoclonus\u2013myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology 62:1526\u20131532","journal-title":"Neurology"},{"key":"9138_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1742-2094-10-10","volume":"10","author":"MR Pranzatelli","year":"2013","unstructured":"Pranzatelli MR, Tate ED, McGee NR et al (2013) BAFF\/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy. J Neuroinflamm 10:10","journal-title":"J Neuroinflamm"},{"key":"9138_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejpain.2008.04.011","volume":"13","author":"L Raffaghello","year":"2009","unstructured":"Raffaghello L, Conte M, De Grandis E, Pistoia V (2009) Immunological mechanisms in opsoclonus\u2013myoclonus associated neuroblastoma. EJPN 13:219\u2013223","journal-title":"EJPN"},{"key":"9138_CR49","first-page":"54","volume":"255","author":"V Fuhlhuber","year":"2008","unstructured":"Fuhlhuber V, Altenkamper S, Bick S et al (2008) Serum and cerebrospinal fluid levels of the B-cell activating factor BAFF in paediatric opsoclonus\u2013myoclonus syndrome\u2014correlation with neuronal surface-binding autoantibodies. J Neurol 255:54\u201354","journal-title":"J Neurol"},{"key":"9138_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cyto.2008.06.001","volume":"44","author":"MR Pranzatelli","year":"2008","unstructured":"Pranzatelli MR, Tate ED, Hoefgen ER, Swan JA, Colliver JA (2008) Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus\u2013myoclonus syndrome. Cytokine 44:26\u201332","journal-title":"Cytokine"},{"key":"9138_CR51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/WCO.0b013e3280126b51","volume":"20","author":"A Wong","year":"2007","unstructured":"Wong A (2007) An update on opsoclonus. Curr Opin Neurol 20:25\u201331","journal-title":"Curr Opin Neurol"},{"key":"9138_CR52","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jns.2009.04.026","volume":"284","author":"KM Scott","year":"2009","unstructured":"Scott KM, Parker F, Heckmann JM (2009) Opsoclonus\u2013myoclonus syndrome and HIV-infection. J Neurol Sci 284:192\u2013195","journal-title":"J Neurol Sci"},{"key":"9138_CR53","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00431-009-1048-3","volume":"169","author":"BM Huber","year":"2010","unstructured":"Huber BM, Strozzi S, Steinlin M, Aebi C, Fluri S (2010) Mycoplasma pneumoniae associated opsoclonus\u2013myoclonus syndrome in three cases. Eur J Pediatr 169:441\u2013445","journal-title":"Eur J Pediatr"},{"key":"9138_CR54","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1002\/mds.22832","volume":"24","author":"O Flabeau","year":"2009","unstructured":"Flabeau O, Meissner W, Foubert-Samier A, Guehl D, Desbordes P, Tison F (2009) Opsoclonus myoclonus syndrome in the context of Salmonellosis. Mov Disord 24:2306\u20132308","journal-title":"Mov Disord"},{"key":"9138_CR55","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1212\/01.wnl.0000262766.50747.27","volume":"68","author":"I Zaganas","year":"2007","unstructured":"Zaganas I, Prinianakis G, Xirouchaki N, Mavridis M (2007) Opsoclonus\u2013myoclonus syndrome associated with cytomegalovirus encephalitis. Neurology 68:1636","journal-title":"Neurology"},{"key":"9138_CR56","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1177\/0883073807307086","volume":"22","author":"JR Crawford","year":"2007","unstructured":"Crawford JR, Kadom N, Santi MR, Mariani B, Lavenstein BL (2007) Human herpesvirus 6 rhombencephalitis in immunocompetent children. J Child Neurol 22:1260\u20131268","journal-title":"J Child Neurol"},{"key":"9138_CR57","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.pediatrneurol.2010.02.009","volume":"42","author":"V Ertekin","year":"2010","unstructured":"Ertekin V, Tan H (2010) Opsoclonus\u2013myoclonus Syndrome Attributable to Hepatitis C Infection. Pediatr Neurol 42:441\u2013442","journal-title":"Pediatr Neurol"},{"key":"9138_CR58","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s00415-009-5046-1","volume":"256","author":"A Ayarza","year":"2009","unstructured":"Ayarza A, Parisi V, Altclas J et al (2009) Opsoclonus\u2013myoclonus-ataxia syndrome and HIV seroconversion. J Neurol 256:1024\u20131025","journal-title":"J Neurol"},{"key":"9138_CR59","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.clineuro.2010.03.024","volume":"112","author":"N Kanjanasut","year":"2010","unstructured":"Kanjanasut N, Phanthumchinda K, Bhidayasiri R (2010) HIV-related opsoclonus\u2013myoclonus-ataxia syndrome: report on two cases. Clin Neurol Neurosurg 112:572\u2013574","journal-title":"Clin Neurol Neurosurg"},{"key":"9138_CR60","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ana.24083","volume":"75","author":"T Armangue","year":"2014","unstructured":"Armangue T, Leypoldt F, Malaga I et al (2014) Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 75:317\u2013323","journal-title":"Ann Neurol"},{"key":"9138_CR61","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1212\/WNL.58.7.1131","volume":"58","author":"A Verma","year":"2002","unstructured":"Verma A, Brozman B (2002) Opsoclonus\u2013myoclonus syndrome following Epstein-Barr virus infection. Neurology 58:1131\u20131132","journal-title":"Neurology"},{"key":"9138_CR62","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1212\/01.WNL.0000154469.27522.EC","volume":"64","author":"JS Khosla","year":"2005","unstructured":"Khosla JS, Edelman MJ, Kennedy N, Reich SG (2005) West Nile virus presenting as opsoclonus\u2013myoclonus cerebellar ataxia. Neurology 64:1095\u20131095","journal-title":"Neurology"},{"key":"9138_CR63","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1055\/s-2007-985906","volume":"38","author":"I Krasenbrink","year":"2007","unstructured":"Krasenbrink I, Fuhlhuber V, Juhasz-Boess I et al (2007) Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus\u2013myoclonus syndrome (OMS). Neuropediatrics 38:114\u2013116","journal-title":"Neuropediatrics"},{"key":"9138_CR64","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.clineuro.2008.03.005","volume":"110","author":"I Markakis","year":"2008","unstructured":"Markakis I, Alexiou E, Xifaras M, Gekas G, Rombos A (2008) Opsoclonus\u2013myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase. Clin Neurol Neurosurg 110:619\u2013621","journal-title":"Clin Neurol Neurosurg"},{"key":"9138_CR65","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1001\/archneur.59.5.868","volume":"59","author":"F Cardoso","year":"2002","unstructured":"Cardoso F (2002) Chorea gravidarum. Arch Neurol-Chicago 59:868\u2013870","journal-title":"Arch Neurol-Chicago"},{"key":"9138_CR66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00041327-200409000-00024","volume":"24","author":"R Koide","year":"2004","unstructured":"Koide R, Sakamoto M, Tanaka K, Hayashi H (2004) Opsoclonus\u2013myoclonus syndrome during pregnancy. J Neuro-Ophthalmol 24:273\u2013273","journal-title":"J Neuro-Ophthalmol"},{"key":"9138_CR67","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/ana.410050502","volume":"5","author":"DS Zee","year":"1979","unstructured":"Zee DS, Robinson DA (1979) A hypothetical explanation of saccadic oscillations. Ann Neurol 5:405\u2013414","journal-title":"Ann Neurol"},{"issue":"Pt 6","key":"9138_CR68","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/brain\/110.6.1699","volume":"110","author":"A Ridley","year":"1987","unstructured":"Ridley A, Kennard C, Scholtz CL, Buttner-Ennever JA, Summers B, Turnbull A (1987) Omnipause neurons in two cases of opsoclonus associated with oat cell carcinoma of the lung. Brain 110(Pt 6):1699\u20131709","journal-title":"Brain"},{"issue":"Pt 1B","key":"9138_CR69","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/brain\/114.1.461","volume":"114","author":"J Ashe","year":"1991","unstructured":"Ashe J, Hain TC, Zee DS, Schatz NJ (1991) Microsaccadic flutter. Brain 114(Pt 1B):461\u2013472","journal-title":"Brain"},{"key":"9138_CR70","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/1531-8249(200101)49:1<24::AID-ANA6>3.0.CO;2-T","volume":"49","author":"R Bhidayasiri","year":"2001","unstructured":"Bhidayasiri R, Somers JT, Kim JI et al (2001) Ocular oscillations induced by shifts of the direction and depth of visual fixation. Ann Neurol 49:24\u201328","journal-title":"Ann Neurol"},{"key":"9138_CR71","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/WNO.0b013e31818eb3a5","volume":"28","author":"AG Shaikh","year":"2008","unstructured":"Shaikh AG, Ramat S, Optican LM, Miura K, Leigh RJ, Zee DS (2008) Saccadic burst cell membrane dysfunction is responsible for saccadic oscillations. J Neuroophthalmol 28:329\u2013336","journal-title":"J Neuroophthalmol"},{"key":"9138_CR72","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00221-004-1989-8","volume":"160","author":"S Ramat","year":"2005","unstructured":"Ramat S, Leigh RJ, Zee DS, Optican LM (2005) Ocular oscillations generated by coupling of brainstem excitatory and inhibitory saccadic burst neurons. Exp Brain Res 160:89\u2013106","journal-title":"Exp Brain Res"},{"key":"9138_CR73","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/brain\/awl309","volume":"130","author":"S Ramat","year":"2007","unstructured":"Ramat S, Leigh RJ, Zee DS, Optican LM (2007) What clinical disorders tell us about the neural control of saccadic eye movements. Brain 130:10\u201335","journal-title":"Brain"},{"key":"9138_CR74","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1212\/01.WNL.0000073271.66866.51","volume":"61","author":"C Helmchen","year":"2003","unstructured":"Helmchen C, Rambold H, Sprenger A, Erdmann C, Binkofski F (2003) f MRIs. Cerebellar activation in opsoclonus: an fMRI study. Neurology 61:412\u2013415","journal-title":"Neurology"},{"key":"9138_CR75","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ejpn.2005.06.007","volume":"9","author":"R Toorn van","year":"2005","unstructured":"van Toorn R, Rabie H, Warwick JM (2005) Opsoclonus\u2013myoclonus in an HIV-infected child on antiretroviral therapy-possible immune reconstitution inflammatory syndrome. Eur J Paediatr Neurol 9:423\u2013426","journal-title":"Eur J Paediatr Neurol"},{"key":"9138_CR76","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1007\/s00415-012-6545-z","volume":"259","author":"L Blumkin","year":"2012","unstructured":"Blumkin L, Kivity S, Lev D et al (2012) A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus\u2013myoclonus ataxia-like syndrome. J Neurol 259:2590\u20132598","journal-title":"J Neurol"},{"key":"9138_CR77","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00415-016-8389-4","volume":"264","author":"SY Oh","year":"2017","unstructured":"Oh SY, Boegle R, Eulenburg PZ, Ertl M, Kim JS, Dieterich M (2017) Longitudinal multi-modal neuroimaging in opsoclonus\u2013myoclonus syndrome. J Neurol 264:512\u2013519","journal-title":"J Neurol"},{"key":"9138_CR78","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1037\/h0055479","volume":"43","author":"RW Sperry","year":"1950","unstructured":"Sperry RW (1950) Neural basis of the spontaneous optokinetic response produced by visual inversion. J Comp Physiol Psychol 43:482\u2013489","journal-title":"J Comp Physiol Psychol"},{"key":"9138_CR79","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1152\/jn.1995.74.5.2179","volume":"74","author":"T Paus","year":"1995","unstructured":"Paus T, Marrett S, Worsley KJ, Evans AC (1995) Extraretinal modulation of cerebral blood flow in the human visual cortex: implications for saccadic suppression. J Neurophysiol 74:2179\u20132183","journal-title":"J Neurophysiol"},{"key":"9138_CR80","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/371511a0","volume":"371","author":"DC Burr","year":"1994","unstructured":"Burr DC, Morrone MC, Ross J (1994) Selective suppression of the magnocellular visual pathway during saccadic eye movements. Nature 371:511\u2013513","journal-title":"Nature"},{"key":"9138_CR81","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/ana.20539","volume":"58","author":"F Blaes","year":"2005","unstructured":"Blaes F, Fuhlhuber V, Korfei M et al (2005) Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann Neurol 58:313\u2013317","journal-title":"Ann Neurol"},{"key":"9138_CR82","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/01.mph.0000212991.64435.f0","volume":"28","author":"MR Pranzatelli","year":"2006","unstructured":"Pranzatelli MR, Tate ED, Travelstead AL et al (2006) Rituximab (anti-CD20) adjunctive therapy for opsoclonus\u2013myoclonus syndrome. J Pediatr Hematol Oncol 28:585\u2013593","journal-title":"J Pediatr Hematol Oncol"},{"key":"9138_CR83","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/pbc.23187","volume":"58","author":"MR Pranzatelli","year":"2012","unstructured":"Pranzatelli MR, Tate ED, Shenoy S, Travelstead AL (2012) Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus\u2013myoclonus. Pediatr Blood Cancer 58:988\u2013991","journal-title":"Pediatr Blood Cancer"},{"key":"9138_CR84","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/mpo.1138","volume":"36","author":"E Rudnick","year":"2001","unstructured":"Rudnick E, Khakoo Y, Antunes NL et al (2001) Opsoclonus\u2013myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children\u2019s Cancer Group Study. Med Pediatr Oncol 36:612\u2013622","journal-title":"Med Pediatr Oncol"},{"key":"9138_CR85","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1542\/peds.109.5.e73","volume":"109","author":"WG Mitchell","year":"2002","unstructured":"Mitchell WG, Davalos-Gonzalez Y, Brumm VL et al (2002) Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae. Pediatrics 109:86\u201398","journal-title":"Pediatrics"},{"key":"9138_CR86","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0887-8994(95)00083-R","volume":"13","author":"MS Hammer","year":"1995","unstructured":"Hammer MS, Larsen MB, Stack CV (1995) Outcome of children with opsoclonus\u2013myoclonus regardless of etiology. Pediatr Neurol 13:21\u201324","journal-title":"Pediatr Neurol"},{"key":"9138_CR87","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1055\/s-2006-955931","volume":"37","author":"K Rostasy","year":"2006","unstructured":"Rostasy K, Wilken B, Baumann M et al (2006) High dose pulsatile dexamethasone therapy in children with opsoclonus\u2013myoclonus syndrome. Neuropediatrics 37:291\u2013295","journal-title":"Neuropediatrics"},{"key":"9138_CR88","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/pbc.21107","volume":"50","author":"F Ertle","year":"2008","unstructured":"Ertle F, Behnisch W, Al Mulla NA et al (2008) Treatment of neuroblastoma-related opsoclonus\u2013myoclonus-ataxia syndrome with high-dose dexamethasone pulses. Pediatr Blood Cancer 50:683\u2013687","journal-title":"Pediatr Blood Cancer"},{"key":"9138_CR89","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/MOP.0b013e32833fde3f","volume":"22","author":"MP Gorman","year":"2010","unstructured":"Gorman MP (2010) Update on diagnosis, treatment, and prognosis in opsoclonus\u2013myoclonus-ataxia syndrome. Curr Opin Pediatr 22:745\u2013750","journal-title":"Curr Opin Pediatr"},{"key":"9138_CR90","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S2352-4642(17)30130-X","volume":"2","author":"PA Alarcon de","year":"2018","unstructured":"de Alarcon PA, Matthay KK, London WB et al (2018) Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial. Lancet Child Adolesc 2:25\u201334","journal-title":"Lancet Child Adolesc"},{"key":"9138_CR91","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejpn.2007.05.005","volume":"12","author":"B Wilken","year":"2008","unstructured":"Wilken B, Baumann M, Bien CG, Hero B, Rostasy K, Hanefeld F (2008) Chronic relapsing opsoclonus\u2013myoclonus syndrome: combination of cyclophosphamide and dexamethasone pulses. Eur J Paediatr Neurol 12:51\u201355","journal-title":"Eur J Paediatr Neurol"},{"key":"9138_CR92","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/00002826-200111000-00007","volume":"24","author":"MR Pranzatelli","year":"2001","unstructured":"Pranzatelli MR, Tate ED, Galvan I, Wheeler A (2001) Controlled pilot study of piracetam for pediatric opsoclonus\u2013myoclonus. Clin Neuropharmacol 24:352\u2013357","journal-title":"Clin Neuropharmacol"},{"key":"9138_CR93","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1177\/0883073814549581","volume":"30","author":"WG Mitchell","year":"2015","unstructured":"Mitchell WG, Wooten AA, O\u2019Neil SH, Rodriguez JG, Cruz RE, Wittern R (2015) Effect of increased immunosuppression on developmental outcome of opsoclonus myoclonus syndrome (OMS). J Child Neurol 30:976\u2013982","journal-title":"J Child Neurol"},{"key":"9138_CR94","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/pbc.22226","volume":"53","author":"CE Catsman-Berrevoets","year":"2009","unstructured":"Catsman-Berrevoets CE, Aarsen FK, van Hemsbergen MLC, van Noesel MM, Hakvoort-Cammel FGAJ, van den Heuvel-Eibrink MM (2009) Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up. Pediatr Blood Cancer 53:1048\u20131053","journal-title":"Pediatr Blood Cancer"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9138-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-9138-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9138-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T19:15:30Z","timestamp":1574795730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-9138-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":94,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["9138"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-9138-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"assertion":[{"value":"31 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}